Home › Funds › Laurion Capital Management LP › MLYS

Laurion Capital Management LP position in MLYS

MINERALYS THERAPEUTICS INC · Health Care

Laurion Capital Management LP reported holding 2,481,698 shares of MLYS (MINERALYS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$62.4M, representing 3.39% of its reported portfolio and ranking #5 among its reported holdings. Laurion Capital Management LP has disclosed MLYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.48M sh
Reported value held$62.37M
Portfolio Weight3.39%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Laurion Capital Management LP's MLYS position evolved

Laurion Capital Management LP first disclosed a stake in MLYS in Q3 2023 at 969,978 shares (US$9.2M). The position peaked in Q2 2026 at 2,506,152 shares, worth US$67.6M. Across 13 filings, Laurion Capital Management LP increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,481,698 shares valued at US$62.4M — a reduction of -24,454 shares quarter over quarter.. Notable position changes include a 34% increase in Q1 2025 (shares fell 15% over the following quarter), a 30% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 969.98K $9.22M New
Q4 2023 1.16M $9.94M Add
Q1 2024 1.30M $16.84M Add
Q2 2024 1.46M $17.04M Add
Q3 2024 1.41M $17.10M Reduce
Q4 2024 1.41M $17.39M Hold
Q1 2025 1.90M $30.14M Add
Q2 2025 1.76M $23.85M Reduce
Q3 2025 1.72M $65.24M Reduce
Q4 2025 1.71M $62.18M Hold
Q1 2026 2.23M $60.47M Add
Q2 2026 2.51M $67.62M Add
Q3 2026 2.48M $62.37M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLYS and 13F data

MLYS (MINERALYS THERAPEUTICS INC) is a Health Care company. 51 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLYS

All MLYS fund holders →

FAQ

How long has Laurion Capital Management LP held MLYS?

Laurion Capital Management LP has disclosed MLYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Laurion Capital Management LP's current position in MLYS?

As of Q3 2026, Laurion Capital Management LP holds 2.48M shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $62.37M, representing 3.39% of its reported portfolio and ranking #5.

Has Laurion Capital Management LP been buying or selling MLYS?

In the latest 13F filing (Q3 2026), Laurion Capital Management LP reduced its position in MLYS. The position peaked in Q2 2026 at 2.51M shares.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.